Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02988934 · ClinicalTrials.gov registry record
The WATS3D (Wide Area Transepithelial Sample Biopsy With 3-Dimensional Computer-Assisted Analysis) U.S. Registry
A clinical trial, sponsored by CDx Diagnostics.
- Terminated
- Registry status
- 3,173
- Enrollment target
NCT02988934 is a clinical trial that was terminated before completion, run by CDx Diagnostics. The registered enrollment target is 3,173 participants.
The verdict
NCT02988934 was terminated before completion, sponsored by CDx Diagnostics.
- TERMINATED
- Registry status
- 3,173 participants
- Enrollment target
Study Summary
The purpose of this study is to create a registry (collect data and keep it in a research database) to learn more about two methods of taking small tissue samples from your esophagus (the esophagus is the tube that carries food and liquid from your mouth to your stomach.). The two methods of sampling are: 1) Using forceps that take biopsies (small tissue samples) from your esophagus, and 2) Using a brush that also takes biopsies from your esophagus. By recording the results of all of your biopsies over many years, it may be possible to find out if the brush biopsy, forceps biopsy, or both can predict which patients with heartburn develop Barrett's esophagus, (an abnormality in the esophagus that may lead to cancer), and which patients with Barrett's esophagus develop precancer and cancer. The data from your biopsies will be used to determine the best way to diagnose esophageal disease. You are being asked to participate in the study because you are receiving an upper endoscopy (a procedure where a tube with a light and camera are inserted in your mouth and down your throat) with forceps and brush biopsies of your esophagus as part of your standard clinical care, and you are between the ages of 18 and 80.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,173 participants |
| Start Date | 2016-04 |
| Est. Completion | 2023-02-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02988934
The ClinicalTrials.gov registry entry for NCT02988934 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3,173 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CDx Diagnostics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02988934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02988934 about?
NCT02988934 is a clinical study titled "The WATS3D (Wide Area Transepithelial Sample Biopsy With 3-Dimensional Computer-Assisted Analysis) U.S. Registry". The purpose of this study is to create a registry (collect data and keep it in a research database) to learn more about two methods of taking small tissue samples from your esophagus (the esophagus is the tube that carries food and liquid from your mouth to your stomach.). The two methods of samplin...
What is the current status of trial NCT02988934?
This trial is currently terminated. The enrollment target is 3,173 participants. The study started on 2016-04. Estimated completion is 2023-02-07.
Who is sponsoring clinical trial NCT02988934?
This trial is sponsored by CDx Diagnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.